Literature DB >> 25834320

Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.

Xue-Xiu Zhang1, Li-Feng Wang1, Lei Jin1, Yuan-Yuan Li1, Shu-Li Hao1, Yan-Chao Shi1, Qing-Lei Zeng1, Zhi-Wei Li1, Zheng Zhang1, George Kk Lau1, Fu-Sheng Wang1.   

Abstract

AIM: To investigate the incidence, characteristics, and risk factors for hepatocellular carcinoma (HCC) in Chinese patients with primary biliary cirrhosis (PBC).
METHODS: We reviewed the data of 52 PBC-associated HCC patients treated at Beijing 302 Hospital from January 2002 to December 2013 and analyzed its incidence and characteristics between the two genders. The risk factors for PBC-associated HCC were analyzed via a case-control study comprising 20 PBC patients with HCC and 77 matched controls without HCC. The matched factors included gender, age, follow-up period and Child-Pugh scores. Conditional logistic regression was used to evaluate the odds ratios of potential risk factors for HCC development. A P < 0.05 was considered statistically significant.
RESULTS: The incidence of HCC in Chinese PBC patients was 4.13% (52/1255) and was significantly higher in the males (9.52%) than in the females (3.31%). Among the 52 PBC patients with HCC, 55.76% (29/52) were diagnosed with HCC and PBC simultaneously, and 5.76% (3/52) were diagnosed with HCC before PBC. The males with PBC-associated HCC were more likely than the females to have undergone blood transfusion (18.75% vs 8.33%, P = 0.043), consumed alcohol (31.25% vs 8.33%, P = 0.010), smoked (31.25% vs 8.33%, P = 0.010), had a family history of malignancy (25% vs 5.56%, P = 0.012), and had serious liver inflammation, as indicated by the elevated levels of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and γ-glutamyl transpeptidase (P < 0.05). Conditional logistic regression analysis revealed that body mass index (BMI) ≥ 25 [adjusted odds ratio (AOR) = 1.116, 95%CI: 1.002-1.244, P = 0.045] and history of alcohol intake (AOR = 10.294, 95%CI: 1.108-95.680, P = 0.040) were significantly associated with increased odds of HCC development in PBC patients.
CONCLUSION: HCC is not rare in Chinese PBC patients. Risk factors for PBC-associated HCC include BMI ≥ 25 and a history of alcohol intake. In addition to regular monitoring, PBC patients may benefit from abstinence from alcohol and body weight control.

Entities:  

Keywords:  Body mass index; Case-control study; Hepatocellular carcinoma; History of alcohol intake; Primary biliary cirrhosis

Mesh:

Year:  2015        PMID: 25834320      PMCID: PMC4375577          DOI: 10.3748/wjg.v21.i12.3554

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

Review 1.  Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis.

Authors:  Yan Liang; Zaixing Yang; Renqian Zhong
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

2.  Gender disparity of hepatocellular carcinoma: the roles of sex hormones.

Authors:  Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Oncology       Date:  2010-07-08       Impact factor: 2.935

3.  Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis.

Authors:  Ersan Ozaslan; Cumali Efe; Alexandra Heurgué-Berlot; Taylan Kav; Chiara Masi; Tugrul Purnak; Luigi Muratori; Yücel Ustündag; Solange Bresson-Hadni; Gérard Thiéfin; Thomas D Schiano; Staffan Wahlin; Paolo Muratori
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-26       Impact factor: 11.382

4.  Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a-PBC).

Authors:  Toshiaki Nakano; Kyoichi Inoue; Junko Hirohara; Seizaburou Arita; Kiyohiro Higuchi; Masao Omata; Gotaro Toda
Journal:  Hepatol Res       Date:  2002-04       Impact factor: 4.288

Review 5.  Primary biliary cirrhosis and hepatocellular carcinoma.

Authors:  Jorge Findor; Xiao-Song He; Juan Sord; Ruben Terg; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2002-08       Impact factor: 9.754

6.  Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies.

Authors:  Carole L Hart; David S Morrison; G David Batty; Richard J Mitchell; George Davey Smith
Journal:  BMJ       Date:  2010-03-11

7.  Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.

Authors:  Ji-Yuan Zhang; Zheng Zhang; Fang Lin; Zheng-Sheng Zou; Ruo-Nan Xu; Lei Jin; Jun-Liang Fu; Feng Shi; Ming Shi; Hui-Fen Wang; Fu-Sheng Wang
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

8.  Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC).

Authors:  A Floreani; M R Biagini; M Chiaramonte; S Milani; C Surrenti; R Naccarato
Journal:  Ital J Gastroenterol       Date:  1993 Nov-Dec

9.  Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis.

Authors:  Cheng Qian; Tingwang Jiang; Weiwei Zhang; Chuanlu Ren; Qianqian Wang; Qin Qin; Jie Chen; Anmei Deng; Renqian Zhong
Journal:  Cytokine       Date:  2013-07-31       Impact factor: 3.861

10.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

View more
  13 in total

1.  Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis.

Authors:  Na Zeng; Weijia Duan; Sha Chen; Shanshan Wu; Hong Ma; Xiaojuan Ou; Hong You; Yuanyuan Kong; Jidong Jia
Journal:  Hepatol Int       Date:  2019-09-25       Impact factor: 6.047

Review 2.  Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.

Authors:  Aylin Tansel; Lior H Katz; Hashem B El-Serag; Aaron P Thrift; Mayur Parepally; Mohammad H Shakhatreh; Fasiha Kanwal
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-12       Impact factor: 11.382

3.  Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting.

Authors:  Dustin E Bosch; Yoh Zen; Sarag A Boukhar; Yongjun Liu; Lin Cheng; Matthew M Yeh
Journal:  Virchows Arch       Date:  2021-08-20       Impact factor: 4.064

4.  Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.

Authors:  Yamini Natarajan; Aylin Tansel; Parth Patel; Kingsley Emologu; Richa Shukla; Zeeshan Qureshi; Hashem B El-Serag; Aaron P Thrift; Fasiha Kanwal
Journal:  Dig Dis Sci       Date:  2020-08-02       Impact factor: 3.199

5.  Primary biliary cirrhosis degree assessment by acoustic radiation force impulse imaging and hepatic fibrosis indicators.

Authors:  Hai-Chun Zhang; Rong-Fei Hu; Ting Zhu; Ling Tong; Qiu-Qin Zhang
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

6.  The expression and clinical significance of serum IL-17 in patients with primary biliary cirrhosis.

Authors:  Qiannan Sun; Qian Wang; Ning Feng; Yan Meng; Bin Li; Demei Luo; Xiaoqian Shang; Jie Lv; Ahmad Maqsuod Monsaf; Changmin Wang; Xiumin Ma
Journal:  Ann Transl Med       Date:  2019-08

7.  Clinical application of thioredoxin reductase as a novel biomarker in liver cancer.

Authors:  Xuping Wu; Qi Wang; Yousheng Lu; Jinye Zhang; Hanwei Yin; Yongxiang Yi
Journal:  Sci Rep       Date:  2021-03-16       Impact factor: 4.379

Review 8.  Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?

Authors:  Hannes Hagström
Journal:  Curr Hepatol Rep       Date:  2017-04-22

9.  Screening therapeutic targets of ribavirin in hepatocellular carcinoma.

Authors:  Chen Xu; Liyun Luo; Yongjun Yu; Zhao Zhang; Yi Zhang; Haimei Li; Yue Cheng; Hai Qin; Xipeng Zhang; Hongmei Ma; Yuwei Li
Journal:  Oncol Lett       Date:  2018-04-20       Impact factor: 2.967

Review 10.  Recent advances in the diagnosis and treatment of primary biliary cholangitis.

Authors:  Ying-Qiu Huang
Journal:  World J Hepatol       Date:  2016-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.